ASX - By Stock
|
CUV |
Re:
Cheer up everyone
|
|
juxtaposer
|
78 |
26K |
0 |
22/05/25 |
22/05/25 |
ASX - By Stock
|
78
|
26K
|
0
|
|
ASX - By Stock
|
CUV |
Road ahead?
|
|
juxtaposer
|
7 |
2.2K |
7 |
04/04/25 |
04/04/25 |
ASX - By Stock
|
7
|
2.2K
|
7
|
|
ASX - By Stock
|
CUV |
Re:
Nauseating
|
|
juxtaposer
|
23 |
7.2K |
1 |
04/04/25 |
04/04/25 |
ASX - By Stock
|
23
|
7.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma's anticancer therapies
|
|
juxtaposer
|
11 |
3.2K |
4 |
07/10/24 |
07/10/24 |
ASX - By Stock
|
11
|
3.2K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze approved by TGA Schedue 2
|
|
juxtaposer
|
45 |
12K |
0 |
30/09/24 |
30/09/24 |
ASX - By Stock
|
45
|
12K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
SPL7013 V Antibiotics
|
|
juxtaposer
|
19 |
4.4K |
3 |
30/09/24 |
30/09/24 |
ASX - By Stock
|
19
|
4.4K
|
3
|
|
ASX - By Stock
|
SPL |
Directors purchases of SPL since April
|
|
juxtaposer
|
2 |
747 |
8 |
16/09/24 |
16/09/24 |
ASX - By Stock
|
2
|
747
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change of Director's Interest Notice - Dr Russell Basser
|
|
juxtaposer
|
35 |
10K |
0 |
16/09/24 |
16/09/24 |
ASX - By Stock
|
35
|
10K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Now where is that Viraleze
|
|
juxtaposer
|
94 |
23K |
3 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
94
|
23K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Now where is that Viraleze
|
|
juxtaposer
|
94 |
23K |
2 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
94
|
23K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Now where is that Viraleze
|
|
juxtaposer
|
94 |
23K |
1 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
94
|
23K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Now where is that Viraleze
|
|
juxtaposer
|
94 |
23K |
6 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
94
|
23K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Now where is that Viraleze
|
|
juxtaposer
|
94 |
23K |
3 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
94
|
23K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Now where is that Viraleze
|
|
juxtaposer
|
94 |
23K |
3 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
94
|
23K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Now where is that Viraleze
|
|
juxtaposer
|
94 |
23K |
4 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
94
|
23K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Why some people got Covid while others didn’t - Study.
|
|
juxtaposer
|
3 |
1.2K |
1 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
3
|
1.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
UIL Limited increase stake in Starpharma
|
|
juxtaposer
|
12 |
2.8K |
4 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
12
|
2.8K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Wealth Destroyer - Down 96%
|
|
juxtaposer
|
32 |
10K |
1 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
32
|
10K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - Jeff Davies
|
|
juxtaposer
|
2 |
1.2K |
3 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
2
|
1.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Accelerated Approval?
|
|
juxtaposer
|
25 |
5.8K |
2 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
25
|
5.8K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Accelerated Approval?
|
|
juxtaposer
|
25 |
5.8K |
2 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
25
|
5.8K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Accelerated Approval?
|
|
juxtaposer
|
25 |
5.8K |
1 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
25
|
5.8K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Accelerated Approval?
|
|
juxtaposer
|
25 |
5.8K |
0 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
25
|
5.8K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Accelerated Approval?
|
|
juxtaposer
|
25 |
5.8K |
3 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
25
|
5.8K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Accelerated Approval?
|
|
juxtaposer
|
25 |
5.8K |
5 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
25
|
5.8K
|
5
|
|
ASX - By Stock
|
SPL |
Accelerated Approval?
|
|
juxtaposer
|
25 |
5.8K |
5 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
25
|
5.8K
|
5
|
|
ASX - By Stock
|
AMT |
Re:
Ann: Recommended cash takeover offer by Allegra Innovations PL
|
|
juxtaposer
|
3 |
1.5K |
1 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
3
|
1.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Priority and Breakthrough Drugs -FDA
|
|
juxtaposer
|
4 |
1.1K |
3 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
4
|
1.1K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
New indications for irinotecan
|
|
juxtaposer
|
19 |
5.5K |
2 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
19
|
5.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
New indications for irinotecan
|
|
juxtaposer
|
19 |
5.5K |
6 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
19
|
5.5K
|
6
|
|
ASX - By Stock
|
SPL |
Priority and Breakthrough Drugs -FDA
|
|
juxtaposer
|
4 |
1.1K |
8 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
4
|
1.1K
|
8
|
|
ASX - By Stock
|
SPL |
The Race to Replace Chemo - Bloomberg
|
|
juxtaposer
|
0 |
271 |
0 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
0
|
271
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
juxtaposer
|
42 |
14K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
42
|
14K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
juxtaposer
|
42 |
14K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
42
|
14K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
juxtaposer
|
42 |
14K |
6 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
42
|
14K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
C'mon Friday 24th May
|
|
juxtaposer
|
12 |
3.9K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
12
|
3.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
C'mon Friday 24th May
|
|
juxtaposer
|
12 |
3.9K |
4 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
12
|
3.9K
|
4
|
|
ASX - By Stock
|
CUV |
Re:
WB is selling at $15
|
|
juxtaposer
|
9 |
3.7K |
5 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
9
|
3.7K
|
5
|
|
ASX - By Stock
|
CUV |
Re:
WB is selling at $15
|
|
juxtaposer
|
9 |
3.7K |
2 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
9
|
3.7K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
juxtaposer
|
9 |
3.8K |
9 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
9
|
3.8K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
juxtaposer
|
161 |
45K |
6 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
161
|
45K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Good news!
|
|
juxtaposer
|
13 |
4.4K |
7 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
13
|
4.4K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Clinical trial thoughts
|
|
juxtaposer
|
40 |
8.9K |
2 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
40
|
8.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Clinical trial thoughts
|
|
juxtaposer
|
40 |
8.9K |
6 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
40
|
8.9K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Clinical trial thoughts
|
|
juxtaposer
|
40 |
8.9K |
0 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
40
|
8.9K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
VIRALEZE™ nasal spray a blow for covid
|
|
juxtaposer
|
37 |
8.2K |
2 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
37
|
8.2K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
DEP Deals
|
|
juxtaposer
|
9 |
3.1K |
4 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
9
|
3.1K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Viraleze shows antiviral efficacy in COVID-19 patients
|
|
juxtaposer
|
74 |
20K |
8 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
74
|
20K
|
8
|
|
ASX - By Stock
|
SPL |
Scripps Eric Topol on nasal spray
|
|
juxtaposer
|
1 |
478 |
4 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
1
|
478
|
4
|
|
ASX - By Stock
|
SPL |
Re:
New CEO’s focus
|
|
juxtaposer
|
85 |
22K |
3 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
85
|
22K
|
3
|
|